Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial Comparing Radical Hysterectomy Plus Tailored Adjuvant Therapy Versus Primary Chemoradiation Therapy in Bulky Early-stage Cervical Cancer (KGOG 1029)

NCT01680523 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT01680523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01680523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial Comparing Radical Hysterectomy Plus Tailored Adjuvant Therapy Versus Primary Chemoradiation Therapy in Bulky Early-stage Cervical Cancer (KGOG 1029)
Lead sponsor
Asan Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2012
Completion date
July 31, 2020
Enrollment
409 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer